Shots:

• The collaboration will deploy ProteinQure's computational methods and structure-based drug design along with AstraZeneca’s expertise in biologics to conduct experimental validation
• The focus of the collaboration is to create therapeutic libraries for accelerating the research and development of peptide therapeutics
• Integrating ProteinQure's computational tools with AstraZeneca’s ability to refine and validate millions of therapeutic candidates in high throughput leading towards the rapid determination of therapeutic leads outside the scope of conventional synthetic antibody libraries

Click here to read full press release/ article 

 Ref: PRNewswire | Image: Pharmashots